Home/ Supplements/ Electrolytes/ Lavish Lash

Lavish Lash

product on market Tablet or Pill Hairgenics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 64% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula contains essential minerals and vitamins, including calcium, phosphorus, and magnesium, which support structural integrity and cellular function. Vitamin C and niacin contribute to antioxidant protection and metabolic processes. However, there is limited evidence specifically linking this combination of ingredients to enhanced lash growth.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Lavish Lash
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
64%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
733 mg (73% DV)
150 mg (15% DV)
Within RDA (0.2× RDA) 13 studies (A:0, B:3)
Vitamin C
120 mg (200% DV)
100 mg (25% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
25 mg (125% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
15 mg (150% DV)
3.0× RDA — within safe limits 2 studies — no high-quality reviews
Sodium
10 mg (1% DV)
7.5 mg (50% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
5 mg (333% DV)
4.2× RDA — above typical dose 76 studies (A:0, B:33)
5 mg (294% DV)
2083.3× RDA — above typical dose 139 studies (A:1, B:44)
5 mg (250% DV)
2.2× RDA — within safe limits 9 studies — no high-quality reviews
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
Iron
3 mg (17% DV)
3000 mcg (1000% DV)
100.0× RDA — above typical dose 27 studies (A:0, B:11)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
112.5 mcg (75% DV)
Within RDA (0.8× RDA) 245 studies (A:4, B:133)
12.5 mcg (18% DV)
Within RDA (0.2× RDA) 173 studies (A:0, B:67)
8 mcg (133% DV)
3.3× RDA — above typical dose 139 studies (A:1, B:44)
Vitamin A
5000 IU (100% DV)
100 IU (25% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
15 IU (50% DV)
Within RDA (0.7× RDA) 179 studies (A:3, B:90)
Lash and Brow Growth Matrix
225.5 mg

Other Ingredients

Vegetable Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take three tablets once daily. Use for a minimum of at least 60 days as eyelashes and eyebrows are the slowest growing hairs on the human body. Best results can be seen after 90 days.

Warnings & Precautions

Warning: Not intended for use by pregnant or nursing women or by any persons under the age of 18.

Warning: Not intended for use by pregnant or nursing women or by any persons under the age of 18. If you are taking any medications, consult your doctor or health care professional before use.

Discontinue use immediately if you experience any adverse reactions.

Keep this product out of reach of children.

In case of accidental overdose, call a doctor or poison control center immediately.

Formulation Notes

Eyelash and eyebrow growth supplement Promotes longer, fuller, looking lashes and brows

Metadata

Product Details

UPC / SKU8 6001 02940 6
DSLD Entry Date2020-07-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID229573
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.